It stuck with me, but, you know, for a different reason
PMC6073405 BPC-157 angiogenic signaling VEGFR2AkteNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing
Clin Toxicol (Phila) 2013
If there is any question, always do an excisional removal for histopathology
[1] [2] Whilst body odour is not listed as an established side effect in the official Summary of Product Characteristics (SmPC), some individuals have anecdotally reported changes in body odour during treatment
Retrieved from Houghton, L